Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.

Tsang, Mazie; LeBlanc, Thomas W · JCO Oncol Pract · 2024

editorial · Level V

Where this comes from

Abstract

@JCOOP_ASCO editorial on unique needs of end-of-life care for different blood cancers discusses: #pallheme improves QOL but less utilized in cancers. Contextualize Weisse et al study. More #pallheme research needed for lymphoma and myeloma in era of cell therapy.

Medical subject headings